ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
Migliori,G.B., Sotgiu,G., Rosales-Klintz, S., Centis, R., D'Ambrosio, L., Abubakar, I., Bothamley, G., Caminero, J. A., Cirillo, D.M., Dara, M., de Vries, G., Aliberti, S., Dinh-Xuan, A.T., Duarte, R., Midulla, F., Solovic, I., Subotic, D.R., Amicosante, M., Correia, A.M., Cirule, A., Gualano, G., Kunst, H., Palmieri, F., Riekstina, V., Tiberi, S., Verduin, R., van der Werf, M.J.
Antimicrobial resistance - Tuberculosis
In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.
European Reference Laboratory Network for TB (ERLTB-Net)
The ERLTB-Net sub-network of reference laboratories from EU/EEA Member States supports harmonisation of methods and laboratory capacity for tuberculosis diagnosis, antimicrobial susceptibility testing and typing in the EU/EEA.
Key messages - Drug-resistant tuberculosis
TB is slowly declining but MDR and XDR TB pose a serious challenge in the attempt to eliminate TB across Europe.